Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tocilizumab”

428 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 428 results

Large-scale testing (Phase 3)Study completedNCT03263715
What this trial is testing

Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

Who this might be right for
Polymyalgia Rheumatica
Medical University of Vienna 39
Testing effectiveness (Phase 2)Study completedNCT03004703
What this trial is testing

ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial

Who this might be right for
Coronary DiseaseMyocardial Infarction
Oslo University Hospital 200
Not applicableStudy completedNCT02608112
What this trial is testing

Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Post-approval studies (Phase 4)Study completedNCT01715831
What this trial is testing

A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488

Who this might be right for
Arthritis, Rheumatoid
Hoffmann-La Roche 26
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Not applicableLooking for participantsNCT06654154
What this trial is testing

Vitamin B12: a Biological Marker of Systemic Disease or Infection Flare-up in Patients Treated with Tocilizumab?

Who this might be right for
Level of Serum Vitamin B12 Level (in Pmol/L) If Relapse of (AI/ID) Under TocilizumabLevel of Serum Vitamin B12 Level (in Pmol/L) If Infection Under Tocilizumab
University Hospital, Clermont-Ferrand 56
Large-scale testing (Phase 3)Study completedNCT00531817
What this trial is testing

Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 619
Large-scale testing (Phase 3)Study completedNCT02101333
What this trial is testing

Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis

Who this might be right for
TAKAYASU ARTERITIS
Assistance Publique - Hôpitaux de Paris 18
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Testing effectiveness (Phase 2)Study completedNCT04445272
What this trial is testing

Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
Fundacion SEIMC-GESIDA 495
Testing effectiveness (Phase 2)Study completedNCT03699631
What this trial is testing

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

Who this might be right for
Hematologic Malignancy
Medical College of Wisconsin 29
Not applicableUnknownNCT04359667
What this trial is testing

Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab

Who this might be right for
COVID-19Severe Pneumonia
University Hospital for Infectious Diseases, Croatia 30
Post-approval studies (Phase 4)UnknownNCT03244709
What this trial is testing

Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.

Who this might be right for
Giant Cell Arteritis
Hospital of Prato 15
Post-approval studies (Phase 4)Looking for participantsNCT04300686
What this trial is testing

A Pilot Study in Severe Patients With Takayasu Arteritis.

Who this might be right for
Takayasu ArteritisTocilizumabAdalimumab+1 more
Shanghai Zhongshan Hospital 40
Large-scale testing (Phase 3)Study completedNCT00773461
What this trial is testing

Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 209
Testing effectiveness (Phase 2)Active Not RecruitingNCT03867617
What this trial is testing

Cell Therapy for Immunomodulation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Thomas Wekerle 12
Not applicableStudy completedNCT01384461
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 251
Post-approval studies (Phase 4)Study completedNCT04730323
What this trial is testing

TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience

Who this might be right for
Covid19
FMH College of Medicine and Dentistry 93
Testing effectiveness (Phase 2)WithdrawnNCT01104480
What this trial is testing

Tocilizumab for Relapsing Polychondritis

Who this might be right for
Relapsing Polychondritis
McMaster Children's Hospital
Testing effectiveness (Phase 2)Study completedNCT01491074
What this trial is testing

Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction

Who this might be right for
Non-ST Elevation Myocardial Infarction
Oslo University Hospital 120
Load More Results